Nanosphere, Inc.  

(Public, NASDAQ:NSPH)   Watch this stock  
Find more results for NSPH
1.43
-0.03 (-2.05%)
Real-time:   3:24PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.41 - 1.45
52 week 1.20 - 3.28
Open 1.45
Vol / Avg. 122,073.00/1.49M
Mkt cap 109.99M
P/E     -
Div/yield     -
EPS -0.54
Shares 76.92M
Beta 3.39
Inst. own 39%
Aug 6, 2014
Q2 2014 Nanosphere Inc Earnings Call - 5:00PM EDT - Add to calendar
Aug 6, 2014
Q2 2014 NANOSPHERE INC Earnings Release Add to calendar
Jun 25, 2014
Nanosphere Inc Receives FDA Clearance for Verigene(R) Enteric Pathogens
Jun 2, 2014
NANOSPHERE INC at Jefferies LLC Healthcare Conference
May 28, 2014
NANOSPHERE INC Annual Shareholder Meeting
May 7, 2014
Q1 2014 NANOSPHERE INC Earnings Conference Call - Webcast
May 7, 2014
Q1 2014 NANOSPHERE INC Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -303.69% -346.40%
Operating margin -292.57% -337.14%
EBITD margin - -316.83%
Return on average assets -71.55% -64.88%
Return on average equity -102.77% -81.17%
Employees 165 -
CDP Score - -

Address

4088 Commercial Avenue
NORTHBROOK, IL 60062
United States - Map
+1-847-4009000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Nanosphere, Inc. develops, manufactures and markets a molecular diagnostics platform, the Verigene System. The Company�s nanoparticle technology provides the ability to run multiple tests simultaneously on the same sample. The Verigene System includes a bench-top molecular diagnostics workstation that is a universal platform for genomic and protein testing. The Verigene System is consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Verigene System provides for multiple tests to be performed on a single platform, including both genomic and protein assays, from a single sample. The Company developed and launched a second generation Verigene System processor (the Processor SP) that handles the same processing steps as the Original Processor and incorporates sample preparation.

Officers and directors

Sheli Z. Rosenberg Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Michael K. McGarrity President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
J. Roger Moody Jr. Chief Financial Officer, Vice President - Finance & Administration, Treasurer, Secretary
Age: 46
Bio & Compensation  - Reuters
Kenneth Bahk Ph.D. Chief Strategy Officer
Age: 40
Bio & Compensation  - Reuters
Gene S. Cartwright Ph.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
Andre de Bruin Independent Director
Age: 67
Bio & Compensation  - Reuters
Erik Holmlin Ph.D. Independent Director
Age: 46
Bio & Compensation  - Reuters
Lorin Jeffry Randall Independent Director
Age: 70
Bio & Compensation  - Reuters
Michael J. Ward Independent Director
Age: 42
Bio & Compensation  - Reuters